| Autor: |
Sarsenova M; Stem Cell Laboratory, National Center for Biotechnology, Astana 010000, Kazakhstan., Raimagambetov Y; National Scientific Center of Traumatology and Orthopedics Named after Academician N.D. Batpenov, Astana 010000, Kazakhstan., Issabekova A; Stem Cell Laboratory, National Center for Biotechnology, Astana 010000, Kazakhstan., Karzhauov M; Stem Cell Laboratory, National Center for Biotechnology, Astana 010000, Kazakhstan., Kudaibergen G; Stem Cell Laboratory, National Center for Biotechnology, Astana 010000, Kazakhstan., Akhmetkarimova Z; Stem Cell Laboratory, National Center for Biotechnology, Astana 010000, Kazakhstan., Batpen A; National Scientific Center of Traumatology and Orthopedics Named after Academician N.D. Batpenov, Astana 010000, Kazakhstan., Ramankulov Y; Stem Cell Laboratory, National Center for Biotechnology, Astana 010000, Kazakhstan.; School of Science and Humanities, Nazarbayev University, Astana 010000, Kazakhstan., Ogay V; Stem Cell Laboratory, National Center for Biotechnology, Astana 010000, Kazakhstan. |
| Abstrakt: |
The regeneration of cartilage and osteochondral defects remains one of the most challenging clinical problems in orthopedic surgery. Currently, tissue-engineering techniques based on the delivery of appropriate growth factors and mesenchymal stem cells (MSCs) in hydrogel scaffolds are considered as the most promising therapeutic strategy for osteochondral defects regeneration. In this study, we fabricated a heparin-conjugated fibrin (HCF) hydrogel with synovium-derived mesenchymal stem cells (SDMSCs), transforming growth factor-β1 (TGF-β1) and bone morphogenetic protein-4 (BMP-4) to repair osteochondral defects in a rabbit model. An in vitro study showed that HCF hydrogel exhibited good biocompatibility, a slow degradation rate and sustained release of TGF-β1 and BMP-4 over 4 weeks. Macroscopic and histological evaluations revealed that implantation of HCF hydrogel with SDMSCs, TGF-β1 and BMP-4 significantly enhanced the regeneration of hyaline cartilage and the subchondral bone plate in osteochondral defects within 12 weeks compared to hydrogels with SDMSCs or growth factors alone. Thus, these data suggest that combined delivery of SDMSCs with TGF-β1 and BMP-4 in HCF hydrogel may synergistically enhance the therapeutic efficacy of osteochondral defect repair of the knee joints. |
